Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: | Psychiatry/Psychology
Search Medical Condition
Psychosis Clinical Trials
A listing of Psychosis medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
Found (1059) clinical trials
Adults with Mild Alzheimer's
A research study is enrolling for those suffering from Mild to Cognitive Impairment due to Alzheimer's Disease.
Memory Loss Clinical Research Study
Participate in a clinical trial exploring memory loss at ActivMed Practices and Research, Inc. in Methuen, MA.
Mild Alzheimer’s Disease
People with Alzheimer ’s disease are asked to participate in a research study being conducted by New York University School of Medicine.
A Study to Evaluate the Safety and Efficacy of an Investigational Medication in Subjects With Mild to Moderate Alzheimer's Disease.
This is a multi-center, randomized, double-blind, placebo-controlled, parallel group 36 week multicenter Phase 2 study of two doses of an investigational medication in adults with mild to moderate Alzheimer's Disease (AD).
A study to evaluate brain imaging and the safety of Leuco-methylthioninium bis(hydromethanesulfonate) (LMTM) in subjects with mild Alzheimer's disease.
The TauRX study is investigating the efficacy and safety of an investigational drug on symptoms of cognitive decline in individuals with mild Alzheimer's disease, compared to a placebo. The study drug is a tablet which is taken by mouth twice per day. The study will last approximately 8 months.
A study to evaluate the safety, tolerability, and efficacy of LY3002813 in individuals with early Alzheimer's disease
The Trailblazer study is investigating the safety, tolerability, and efficacy of an investigational drug on symptoms of cognitive and functional decline in individuals with early Alzheimer's disease. The study drug is an infusion that will be administered once per week for 75 weeks. The study will last approximately two and ...
Graduate II Study: Safety and Efficacy Study of Gantenerumab in Participants With Early Alzheimer's Disease (AD)
Are you starting to experience memory problems? Are slight memory problems affecting your ability to do regular activities? Has anyone noticed a change in your memory? Do you have a family history of Alzheimer’s Disease? If so, you may be experiencing the first signs of memory loss. You may qualify ...
Tolerability, Pharmacokinetics, and Efficacy of MP-101 in the Treatment of Patients With Dementia-Related Psychosis and/or Agitation and Aggression
A ten-week study to assess MP-101 in Dementia-Related Psychosis and/or Agitation and Aggression
Dementia-related Hallucinations and / or Delusions
The purpose of this study is to understand whether the drug, pimavanserin, improves symptoms of hallucinations and/or delusions experienced in people with dementia.
Early stage Alzheimer's disease
Clinical research study of an investigational drug that may help slow or stop memory loss in people with early stages of Alzheimer's disease.